A new, streamlined AAV purification process that is both universal and scalable could ease commercialization constraint.

The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

After spending years developing its endoscopic device treatment for patients with Type 2 diabetes, Fractyl Health is now fully pivoting its research toward obesity and people on GLP-1s.

The partners will adapt Eukarÿs' C3P3 engineered enzyme tech to work with adeno-associated virus vectors to boost biomanufacturing yields.

Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...